These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12459349)

  • 1. Tumor hypoxia is important in radiotherapy, but how should we measure it?
    Brown JM; Le QT
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1299-301. PubMed ID: 12459349
    [No Abstract]   [Full Text] [Related]  

  • 2. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
    Cohen NA; Lai SY; Ziober AF; Ziober BL
    Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia in head and neck cancer: how much, how important?
    Janssen HL; Haustermans KM; Balm AJ; Begg AC
    Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Pastorek J; Karapantzos I; Gatter KC; Harris AL;
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):67-71. PubMed ID: 15093900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment.
    Papandreou I; Krishna C; Kaper F; Cai D; Giaccia AJ; Denko NC
    Cancer Res; 2005 Apr; 65(8):3171-8. PubMed ID: 15833847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.
    Nordsmark M; Eriksen JG; Gebski V; Alsner J; Horsman MR; Overgaard J
    Radiother Oncol; 2007 Jun; 83(3):389-97. PubMed ID: 17499868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos C; Turley H; Talks K; Gatter KC; Harris AL
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1192-202. PubMed ID: 12128120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia in head and neck cancer.
    Isa AY; Ward TH; West CM; Slevin NJ; Homer JJ
    Br J Radiol; 2006 Oct; 79(946):791-8. PubMed ID: 16854964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
    Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
    Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.
    Beasley NJ; Leek R; Alam M; Turley H; Cox GJ; Gatter K; Millard P; Fuggle S; Harris AL
    Cancer Res; 2002 May; 62(9):2493-7. PubMed ID: 11980639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
    Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E
    Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor (HIF) in human tumorigenesis.
    Mabjeesh NJ; Amir S
    Histol Histopathol; 2007 May; 22(5):559-72. PubMed ID: 17330811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
    Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C
    Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer.
    Giatromanolaki A; Harris AL
    Anticancer Res; 2001; 21(6B):4317-24. PubMed ID: 11908686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
    Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
    BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
    Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is HIF-1alpha a good marker for tumor hypoxia?
    Begg AC
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):917-9. PubMed ID: 12829124
    [No Abstract]   [Full Text] [Related]  

  • 20. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    Janssen HL; Haustermans KM; Sprong D; Blommestijn G; Hofland I; Hoebers FJ; Blijweert E; Raleigh JA; Semenza GL; Varia MA; Balm AJ; van Velthuysen ML; Delaere P; Sciot R; Begg AC
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1537-49. PubMed ID: 12459383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.